Abacus dx is pleased to announce the release of the Vircell VirClia® Ross River Virus (RRV) IgG and IgM Monotest into the Australian market.
We would like to share with you a recent publication on the benefits of the Vircell VirClia analyser written by Jamie Laughlin, Head of Operations at the South West London Pathology (SWLP), St George’s University Hospitals NHS Foundation Trust, UK.
The AccuSet™ Dengue performance panel (BB08450153) is intended for use by manufacturers, researchers, and clinical laboratories to validate or verify dengue test methods. Well characterized samples and comprehensive data sheets are provided.
Tick borne diseases comprise a group of infections transmitted to humans by the bite of ticks infected with bacteria, viruses, or parasites. Tick borne diseases affecting humans include: Lyme disease, relapsing fever, Babesiosis, Anaplasmosis, Ehrlichiosis, Q fever, tick-borne encephalitis and spotted fever among others.
Vircell is pleased to announce that VirClia® has a new logo. The design change will be gradually implemented in the packaging, therefore the current and the new logo will coexist for some time. We hope you like it!
A growing number of laboratories around the world are using Vircell Extraction & Amplification controls for PCR QC purposes; to comply with lab accreditation and to improve patient care.
The Virclia® system it is a small automated platform that will serve as the ideal complementary system for those esoteric and low volume tests. To improve turn around time and the efficiency in your laboratory.
Abacus dx is pleased to inform you about the NEW HCV RNA Linearity Panel available from SeraCare.
Abacus dx is pleased to announce the new range of VIASURE products now available from CerTest.